Brain Neoplasms D001932

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Nervous System Neoplasms » Central Nervous System Neoplasms » Brain Neoplasms

Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Brain Neoplasms

Description

Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.   MeSH

Subtype Terms (5)

Cerebral Ventricle Neoplasms
 

Infratentorial Neoplasms
6 drugs (5 approved, 1 experimental)

Neurocytoma
2 approved drugs

Pinealoma
26 drugs (19 approved, 7 experimental)

Supratentorial Neoplasms
11 drugs (7 approved, 4 experimental)


Approved Indicated Drugs (1)

Phase 2 Indicated Drugs (211)

Phase 1 Indicated Drugs (168)


Organization Involved with Phase 2 Indications (182)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.